Bionyra Pharma

About Bionyra Pharma

Bionyra Pharma is a development-stage biopharmaceutical company focused on creating next-generation biologics for severe immune-mediated inflammatory diseases. It develops mono and multispecific antibodies designed to target novel immune pathways with the goal of achieving deeper and more durable disease control. The company’s initial therapeutic focus includes atopic dermatitis and inflammatory bowel disease. It is advancing a clinical and near-clinical pipeline that leverages half-life extension engineering to optimize dosing and patient outcomes.